<p>Most active non-cyclic urea derivative (141W94) mapped onto: (A) hypothesis 1(four feature mapping) and (B) structure based pharmacophore (five feature mapping). Most active cyclic urea derivative (15) mapped onto: (C) hypothesis 1 (four feature mapping) and (D) structure based pharmacophore (five feature mapping).</p
<p>Best pharmacophore validation results per set and 5 or 6 feature combination.</p
A pharmacophore analysis approach was used to investigate and compare different classes of compounds...
<p>Pharmacophoric interaction of most active compound 9s onto the pharmacophore obtained from struct...
<p>Mapping of most active compound 9r (cyclic urea derivative) onto the generated pharmacophore mode...
<p>Mapping of another most active compound 9s (cyclic urea derivative) onto the generated pharmacoph...
<p>Mapping of another least active compound 8u (cyclic cyanoguanidine derivative) onto the generated...
<p>Mapping of least active compound 8t (cyclic cyanoguanidine derivative) onto the generated pharmac...
<p>(A) The structure of text sets. (B) The structure of training sets. (C) Pharmacophore model of 5-...
A quantitative structure-activity relationship (QSAR) study was performed on a set of amino-substitu...
Three-dimensional pharmacophore hypothesis was built on the basis of a set of known cyclooxygenase i...
<p>Mapping of compound 8r (cyclic cyanoguanidine derivative) onto the generated pharmacophore model ...
<p>Cyclic cyanoguanides and cyclic urea derivatives with various substitutions at P2/P2′ positions a...
AbstractA quantitative structure–activity relationship (QSAR) study was performed on a set of amino-...
<p>Ligand-based pharmacophore model (LB_Model) and its overlay on most active compound of training s...
<p>Plots of HOMO and LUMO of most active compound 1 along with potent hits KM09155, HTS00581, HTS058...
<p>Best pharmacophore validation results per set and 5 or 6 feature combination.</p
A pharmacophore analysis approach was used to investigate and compare different classes of compounds...
<p>Pharmacophoric interaction of most active compound 9s onto the pharmacophore obtained from struct...
<p>Mapping of most active compound 9r (cyclic urea derivative) onto the generated pharmacophore mode...
<p>Mapping of another most active compound 9s (cyclic urea derivative) onto the generated pharmacoph...
<p>Mapping of another least active compound 8u (cyclic cyanoguanidine derivative) onto the generated...
<p>Mapping of least active compound 8t (cyclic cyanoguanidine derivative) onto the generated pharmac...
<p>(A) The structure of text sets. (B) The structure of training sets. (C) Pharmacophore model of 5-...
A quantitative structure-activity relationship (QSAR) study was performed on a set of amino-substitu...
Three-dimensional pharmacophore hypothesis was built on the basis of a set of known cyclooxygenase i...
<p>Mapping of compound 8r (cyclic cyanoguanidine derivative) onto the generated pharmacophore model ...
<p>Cyclic cyanoguanides and cyclic urea derivatives with various substitutions at P2/P2′ positions a...
AbstractA quantitative structure–activity relationship (QSAR) study was performed on a set of amino-...
<p>Ligand-based pharmacophore model (LB_Model) and its overlay on most active compound of training s...
<p>Plots of HOMO and LUMO of most active compound 1 along with potent hits KM09155, HTS00581, HTS058...
<p>Best pharmacophore validation results per set and 5 or 6 feature combination.</p
A pharmacophore analysis approach was used to investigate and compare different classes of compounds...
<p>Pharmacophoric interaction of most active compound 9s onto the pharmacophore obtained from struct...